Report post

Who is Cero Therapeutics?

About CERo Therapeutics, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer.

Is Cero launching a new drug in 2024?

As we have previously reported, CERo plans to file an Investigational New Drug (IND) application in the first half of 2024, and is targeting initial treatment of AML patients as well as B Cell lymphoma patients before the end of the year," said Brian G Atwood, CERo’s Chairman and Chief Executive Officer. About CERo Therapeutics, Inc.

Who are Cero and PBAX?

Upon closing of the transaction, anticipated to occur in the second half of 2023, the combined company will be named CERo Therapeutics Holdings, Inc. and will be led by CERo and PBAX’s founding members, including Daniel Corey, M.D., CERo’s CEO, Chris Ehrlich, PBAX’s CEO, and Brian G. Atwood, the Chairman of PBAX.

The World's Leading Crypto Trading Platform

Get my welcome gifts